About Index Trending news
Analyze
Pricing
Polyneuron

Polyneuron

Work at Polyneuron? Add yourself to this profile

Polyneuron

Swiss biotech start-up. We’re using our Antibody-Catch® technology to develop the most accurate treatment of rare autoimmune disorders.
Edit Profile
More info

Elsewhere

Companies in the same industry

Takeda Pharmaceutical Company Ltd Takeda Pharmaceutical Company Ltd Aratana Therapeutics Aratana Therapeutics Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical SutroVax SutroVax Entegrion Entegrion Strongbridge Biopharma Strongbridge Biopharma Tricida, Inc. Tricida, Inc. Oculis Oculis Euclises Pharmaceuticals Euclises Pharmaceuticals Genialis Genialis

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1
Add info
Latest funding
Seed fund
Zürcher Kantonalbank, EVA Basel
Employees

Unknown size

Locations
HQ
Switzerland
Headquarters
Seed fund
startupticker

Polyneuron Pharmaceuticals closes CHF 3 Million seed financing round.ch | The Swiss Startup News channel

Health Funding
Polyneuron
Polyneuron